Suppliers / Alp Pharm Beijing

Alp Pharm Beijing

Updated 9 July 2026

Alp Pharm Beijing is an API manufacturer. It holds 54 active US drug master files.

54
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Bacitracin US FDA 2
Calcipotriol US FDA 2
(21R)-Argatroban US FDA 1
Abiraterone US FDA 1
Alogliptin US FDA 1
Apixaban US FDA 1
Azilsartan Medoxomil US FDA 1
Besifloxacin US FDA 1
Bivalirudin US FDA 1
Bosutinib US FDA 1
Show all 30 molecules on file
Cetrorelix US FDA 1
Clevidipine US FDA 1
D-Methionine US FDA 1
Dapagliflozin US FDA 1
Daridorexant US FDA 1
Dasatinib US FDA 1
Difelikefalin US FDA 1
Doxapram US FDA 1
Doxercalciferol US FDA 1
Dronedarone US FDA 1
Empagliflozin US FDA 1
Eptifibatide US FDA 1
Exenatide US FDA 1
Goserelin US FDA 1
Iopromide US FDA 1
Istradefylline US FDA 1
Lanreotide US FDA 1
Lapatinib US FDA 1
Leuprolide US FDA 1
Liraglutide US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Alp Pharm Beijing comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 2 active litigation matters are on record.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability